Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David Sahner"'
Autor:
David Sahner, Richard J. Williams
An approach is described to building a clinical decision support tool which leverages a partially instantiated graphical model optimized through quantum annealing. Potential advantages of such a strategy include the practical, and potentially real-ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9701f0a379d8c99bee68f92784baf7
https://doi.org/10.1101/2020.12.13.20248138
https://doi.org/10.1101/2020.12.13.20248138
Autor:
David Sahner, David C. Spellmeyer
Artificial intelligence (AI), specifically machine learning (ML) models that make biological or clinical predictions, may indeed be transformative within the realms of drug and biologic discovery and development. ML has already made inroads within th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55622a5f67928fc7a52a03efa247d631
https://doi.org/10.1016/b978-0-12-815585-1.00028-0
https://doi.org/10.1016/b978-0-12-815585-1.00028-0
Autor:
J Michael, Kilby, R Pat, Bucy, Donna, Mildvan, Margaret, Fischl, Jorge, Santana-Bagur, Jeff, Lennox, Chris, Pilcher, Andrew, Zolopa, Jody, Lawrence, Richard B, Pollard, Raphaelle El, Habib, David, Sahner, Lawrence, Fox, Evgenia, Aga, Ronald J, Bosch, Ronald, Mitsuyasu
Publikováno v:
The Journal of Infectious Diseases. 194:1672-1676
Strategies to limit life-long dependence on antiretroviral therapy (ART) are needed. We randomized 81 human immunodeficiency virus (HIV)-infected subjects to 4 interventional arms involving continued ART plus ALVAC vCP1452 (or placebo) with or withou
Autor:
Alan L. Landay, John L. Fahey, Ellen S. Chan, Ann Namkung, Lawrence Fox, Hernan Valdez, Spyros A. Kalams, David Sahner, Anne Sevin, Ronald B. Moss, John Spritzler, Michael M. Lederman, Scharla Estep, Richard B. Pollard, Ronald T. Mitsuyasu
Publikováno v:
The Journal of infectious diseases. 187(2)
To ascertain whether CD4(+) lymphocyte increases induced by interleukin (IL)-2 enhanced in vivo immune responses, 38 human immunodeficiency virus (HIV)-infected patients who had received highly active antiretroviral therapy (HAART) or HAART and IL-2
Autor:
David Sahner, Nina Mufti, Annette Marcantonio, Lori K. Samford, Michael A. Eldon, Jonathan D. Lee, Alan R. Kugler
Publikováno v:
Blood. 110:4988-4988
Nektar is developing Amphotericin B Inhalation Powder (ABIP; NKTR-024) to prevent invasive pulmonary fungal infections in immunocompromised patients. NKTR-024 is a proprietary dry-powder amphotericin B (AmB) formulation that is delivered to the patie